EBR/UCB (EBR/UCB)

Euronext Brussels: EBR/UCB · EUR

€279

+8.20 (+3.0%)· Recorded snapshot

Market cap	53.1B
Revenue (ttm)	8.5B
Net income (ttm)	2.2B
EPS (ttm)	€11.3
Shares out	190.7M
P/E (trailing)	24.6x
P/E (forward)	20.0x
Dividend	€1.45 (0.52%)
Volume	51,340
Beta	0.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.5B
Net income (ttm): 2.2B
EPS (ttm): €11.3
P/E (trailing): 24.6x
P/E (forward): 20.0x
Market cap: 53.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E20

P25 n/aP50 n/aP75 n/a

Trailing P/E24.6

P25 n/aP50 n/aP75 n/a

ROE20.6

P25 n/aP50 n/aP75 n/a

ROIC15

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All EBR/UCB indicators

Market & fundamental data

Available fields

270

Groups with data

Currency

EUR

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2027-02-25
Employees	9,000
Employees change	-765
Employees growth	-7.83%
Enterprise value	EUR 56B
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1925
Industry	Biotechnology
Is primary listing	Yes
ISIN number	BE0003739530
Last earnings date	2026-07-30
Last refreshed	2026-10-29
Last stock split date	1999-01-04
Last stock split type	Forward
Market cap	EUR 53.1B
Next earnings date	2027-02-25
Price	EUR 278.70
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	ebr/UCB
Website	https://www.ucb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.95x
Average P/E ratio (10Y)	27.93x
Average P/E ratio (3Y)	42.86x
Average P/E ratio (5Y)	35.01x
Earnings yield	4.06%
EV/Earnings	24.79x
EV/EBIT	21.65x
EV/EBITDA	17.33x
EV/FCF	35.14x
EV/Sales	6.38x
FCF / EV yield	2.85%
FCF yield	3%
Forward P/E	19.98x
Graham number	124.77852
Graham upside	-53.87%
Industry P/E	28.77x
Lynch fair value	EUR 277.94
Lynch upside	2.75%
P/(FCF - SBC) ratio	29.97x
P/(OCF - SBC) ratio	24.3x
P/B ratio	4.43x
P/E ratio	24.62x
P/FCF ratio	33.32x
P/OCF ratio	26.46x
P/S ratio	6.05x
PEG ratio	0.95x
Price / tangible book value	114.36x
Price/EBITDA ratio	16.44x
Sector forward P/E	22.94x
Sector P/E	29.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.47%
EBITDA margin	36.81%
Effective tax rate	13.38%
FCF margin	18.16%
Gross margin	76.22%
Operating margin	29.47%
Pretax margin	29.72%
Profit margin	25.74%
Profit per employee	EUR 243,778
Profitable quarters	36
Profitable years	24
Revenue per employee	EUR 947,111
ROA	8.3%
ROA (5Y)	4.05%
ROCE	15.61%
ROE	20.57%
ROE (5Y)	9.64%
ROIC	15.03%
ROIC (5Y)	8.46%
SBC / revenue	-2.03%
Tax / revenue	3.98%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	64.86%
EPS growth (Q)	134.84%
EPS growth (QoQ)	2.48%
EPS growth 10Y	22.99%
EPS growth 3Y	80.84%
EPS growth 5Y	24.6%
EPS growth quarters	4
EPS growth years	2
FCF growth	15.52%
FCF growth (Q)	-77.91%
FCF growth (QoQ)	-90.76%
FCF growth 3Y	24.9%
FCF growth 5Y	13.41%
Gross profit growth	29.29%
Gross profit growth (Q)	29.08%
Gross profit growth 3Y	21.45%
Gross profit growth 5Y	10.28%
Net income growth	64.72%
Net income growth (Q)	133.9%
Net income growth (QoQ)	2.59%
Net income growth 3Y	80.35%
Net income growth 5Y	24.55%
Net income growth quarters	4
Net income growth years	2
OCF growth	23.67%
OCF growth (Q)	-48.1%
OCF growth (QoQ)	-76.65%
OCF growth 10Y	13.67%
OCF growth 3Y	23.01%
OCF growth 5Y	12.51%
Operating income growth	106.58%
Operating income growth (Q)	105.04%
Operating income growth 3Y	63.81%
Operating income growth 5Y	19.38%
Revenue growth	24.47%
Revenue growth (Q)	22.46%
Revenue growth (QoQ)	0.38%
Revenue growth 10Y	9.29%
Revenue growth 3Y	17.32%
Revenue growth 5Y	9.78%
Revenue growth quarters	6
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -401M
Depreciation and amortization	EUR 626M
EBIT	EUR 2.5B
EBITDA	EUR 3.1B
EPS	EUR 11.32
FCF per share	EUR 8.12
Financing cash flow	EUR 98M
Free cash flow	EUR 1.5B
Free cash flow minus SBC	EUR 1.7B
Gross profit	EUR 6.5B
Income taxes	EUR 339M
Investing cash flow	EUR -2.9B
Net borrowing	EUR 606M
Net cash flow	EUR -845M
Net income	EUR 2.2B
Operating cash flow minus SBC	EUR 2.1B
Operating income	EUR 2.5B
Revenue	EUR 8.5B
Stock-based compensation	EUR -173M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	EUR 61.12
Debt / EBITDA	1.14
Debt / equity	0.31
Debt / FCF	2.32
Goodwill	EUR 7.8B
Interest coverage	29.9
Long-term assets	EUR 15.2B
Long-term liabilities	EUR 4.4B
Net cash (debt)	EUR -2.8B
Net cash / market cap	-5.47%
Net debt / EBITDA	0.9
Net debt / equity	0.24
Net debt / FCF	1.82
Piotroski F-Score	5
Property, plant and equipment	EUR 2.1B
Shareholders' equity	EUR 11.7B
Tangible book value	EUR 451M
Tangible book value per share	EUR 2.37
Total assets	EUR 20.6B
Total cash	EUR 766M
Total debt	EUR 3.6B
Total liabilities	EUR 9B
WACC	5.1%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	EUR 5.5B
Current liabilities	EUR 4.5B
Current ratio	1.2
Inventory turnover	1.31
Net working capital	EUR 374M
Quick ratio	0.72
Working capital	EUR 923M
Working capital turnover	7.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.07%
Dividend growth	4.32%
Dividend growth (10Y)	2.8%
Dividend growth (3Y)	2.92%
Dividend growth (5Y)	2.69%
Dividend growth years	16
Dividend payment date	2026-05-06
Dividend payment years	47
Dividend payout frequency	Annual
Dividend per share	EUR 1.45
Dividend yield	0.52%
Ex-dividend date	2026-05-04
FCF payout ratio	17.86%
Last dividend	EUR 1.45
Payout ratio	12.58%
Shareholder yield	0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	348.17%
10Y return CAGR	17.32%
10Y total return	393.67%
150-day SMA	EUR 235.71
15Y price change	780.3%
15Y return CAGR	16.94%
15Y total return	946.48%
1D price change	3.03%
1M price change	30.82%
1M total return	30.82%
1W price change	7.29%
1W total return	7.29%
1Y price change	22.36%
1Y return CAGR	22.92%
1Y total return	22.9%
20-day SMA	EUR 224.38
200-day SMA	EUR 241.87
20Y price change	466.08%
20Y return CAGR	10.68%
20Y total return	660.43%
3M price change	11.11%
3M total return	11.11%
3Y price change	301.39%
3Y return CAGR	59.9%
3Y total return	308.95%
50-day SMA	EUR 217.20
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 289.50
52-week high date	2026-02-19
52-week low	EUR 197.45
52-week low date	2026-10-14
5Y price change	170.82%
5Y return CAGR	22.98%
5Y total return	181.28%
6M price change	22.09%
6M total return	22.63%
All-time high	EUR 289.50
All-time high date	2026-02-19
All-time low	EUR 0.23
All-time low date	1981-02-02
Average true range (ATR)	EUR 9.15
Average volume	307.1K
Beta (1Y)	0.08
Beta (2Y)	0.69
Beta (5Y)	0.19
Change from 52-week high	-3.73%
Change from 52-week low	41.15%
Change from all-time high	-3.97%
Change from all-time low	122,366.96%
Change from open	2.92%
Day's gap	0.11%
Dollar volume	EUR 14.3M
High price	EUR 279.90
Low price	EUR 270.80
Monthly RSI	65.66
Open price	EUR 270.80
Position in 52-week range	86.81%
Previous close	EUR 270.50
Price vs 150-day SMA	17.94%
Price vs 20-day SMA	23.9%
Price vs 200-day SMA	14.94%
Price vs 50-day SMA	27.99%
Relative volume	0.17
RSI	79.59
Sharpe ratio	0.7
Sharpe ratio (3Y)	1.45
Sharpe ratio (5Y)	0.71
Sortino ratio	1.25
Sortino ratio (3Y)	2.44
Sortino ratio (5Y)	1.22
Volume	51.3K
Weekly RSI	65.31
YTD price change	16.51%
YTD total return	17.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120.1M
Shares change (QoQ)	-0.08%
Shares change (YoY)	-0.07%
Shares held by institutions	35.57%
Shares outstanding	190.7M

Deeper analysis on EBR/UCB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this EBR/UCB report

Is a complete EBR/UCB research report available?

No complete published report is available for ebr/UCB (EBR/UCB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

53.1B

Revenue (ttm)

8.5B

Net income (ttm)

2.2B

EPS (ttm)

€11.3

Shares out

190.7M

P/E (trailing)

24.6x

P/E (forward)

20.0x

Dividend

€1.45 (0.52%)

Volume

51,340

Beta

0.19

Metric

Value

Amount currency

EUR

Country

Belgium

Country code

Earnings date

2027-02-25

Employees

9,000

Employees change

-765

Employees growth

-7.83%

Enterprise value

EUR 56B

Exchange

Euronext Brussels

Financial currency

EUR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1925

Industry

Biotechnology

Is primary listing

Yes

ISIN number

BE0003739530

Last earnings date

2026-07-30

Last refreshed

2026-10-29

Last stock split date

1999-01-04

Last stock split type

Forward

Market cap

EUR 53.1B

Next earnings date

2027-02-25

Price

EUR 278.70

Price currency

EUR

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-29

Symbol

ebr/UCB

Website

https://www.ucb.com

Metric

Value

Adjusted P/E ratio

20.95x

Average P/E ratio (10Y)

27.93x

Average P/E ratio (3Y)

42.86x

Average P/E ratio (5Y)

35.01x

Earnings yield

4.06%

EV/Earnings

24.79x

EV/EBIT

21.65x

EV/EBITDA

17.33x

EV/FCF

35.14x

EV/Sales

6.38x

FCF / EV yield

2.85%

FCF yield

Forward P/E

19.98x

Graham number

124.77852

Graham upside

-53.87%

Industry P/E

28.77x

Lynch fair value

EUR 277.94

Lynch upside

2.75%

P/(FCF - SBC) ratio

29.97x

P/(OCF - SBC) ratio

24.3x

P/B ratio

4.43x

P/E ratio

24.62x

P/FCF ratio

33.32x

P/OCF ratio

26.46x

P/S ratio

6.05x

PEG ratio

0.95x

Price / tangible book value

114.36x

Price/EBITDA ratio

16.44x

Sector forward P/E

22.94x

Sector P/E

29.62x

Metric

Value

EBIT margin

29.47%

EBITDA margin

36.81%

Effective tax rate

13.38%

FCF margin

18.16%

Gross margin

76.22%

Operating margin

29.47%

Pretax margin

29.72%

Profit margin

25.74%

Profit per employee

EUR 243,778

Profitable quarters

Profitable years

Revenue per employee

EUR 947,111

ROA

8.3%

ROA (5Y)

4.05%

ROCE

15.61%

ROE

20.57%

ROE (5Y)

9.64%

ROIC

15.03%

ROIC (5Y)

8.46%

SBC / revenue

-2.03%

Tax / revenue

3.98%

Metric

Value

EPS growth

64.86%

EPS growth (Q)

134.84%

EPS growth (QoQ)

2.48%

EPS growth 10Y

22.99%

EPS growth 3Y

80.84%

EPS growth 5Y

24.6%

EPS growth quarters

EPS growth years

FCF growth

15.52%

FCF growth (Q)

-77.91%

FCF growth (QoQ)

-90.76%

FCF growth 3Y

24.9%

FCF growth 5Y

13.41%

Gross profit growth

29.29%

Gross profit growth (Q)

29.08%

Gross profit growth 3Y

21.45%

Gross profit growth 5Y

10.28%

Net income growth

64.72%

Net income growth (Q)

133.9%

Net income growth (QoQ)

2.59%

Net income growth 3Y

80.35%

Net income growth 5Y

24.55%

Net income growth quarters

Net income growth years

OCF growth

23.67%

OCF growth (Q)

-48.1%

OCF growth (QoQ)

-76.65%

OCF growth 10Y

13.67%

OCF growth 3Y

23.01%

OCF growth 5Y

12.51%

Operating income growth

106.58%

Operating income growth (Q)

105.04%

Operating income growth 3Y

63.81%

Operating income growth 5Y

19.38%

Revenue growth

24.47%

Revenue growth (Q)

22.46%

Revenue growth (QoQ)

0.38%

Revenue growth 10Y

9.29%

Revenue growth 3Y

17.32%

Revenue growth 5Y

9.78%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -401M

Depreciation and amortization

EUR 626M

EBIT

EUR 2.5B

EBITDA

EUR 3.1B

EPS

EUR 11.32

FCF per share

EUR 8.12

Financing cash flow

EUR 98M

Free cash flow

EUR 1.5B

Free cash flow minus SBC

EUR 1.7B

Gross profit

EUR 6.5B

Income taxes

EUR 339M

Investing cash flow

EUR -2.9B

Net borrowing

EUR 606M

Net cash flow

EUR -845M

Net income

EUR 2.2B

Operating cash flow minus SBC

EUR 2.1B

Operating income

EUR 2.5B

Revenue

EUR 8.5B

Stock-based compensation

EUR -173M

Metric

Value

Altman Z-Score

4.48

Book value per share

EUR 61.12

Debt / EBITDA

1.14

Debt / equity

0.31

Debt / FCF

2.32

Goodwill

EUR 7.8B

Interest coverage

29.9

Long-term assets

EUR 15.2B

Long-term liabilities

EUR 4.4B

Net cash (debt)

EUR -2.8B

Net cash / market cap

-5.47%

Net debt / EBITDA

0.9

Net debt / equity

0.24

Net debt / FCF

1.82

Piotroski F-Score

Property, plant and equipment

EUR 2.1B

Shareholders' equity

EUR 11.7B

Tangible book value

EUR 451M

Tangible book value per share

EUR 2.37

Total assets

EUR 20.6B

Total cash

EUR 766M

Total debt

EUR 3.6B

Total liabilities

EUR 9B

WACC

5.1%

Metric

Value

Asset turnover

0.45

Current assets

EUR 5.5B

Current liabilities

EUR 4.5B

Current ratio

1.2

Inventory turnover

1.31

Net working capital

EUR 374M

Quick ratio

0.72

Working capital

EUR 923M

Working capital turnover

7.37

Metric

Value

Buyback yield / dilution

0.07%

Dividend growth

4.32%

Dividend growth (10Y)

2.8%

Dividend growth (3Y)

2.92%

Dividend growth (5Y)

2.69%

Dividend growth years

Dividend payment date

2026-05-06

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

EUR 1.45

Dividend yield

0.52%

Ex-dividend date

2026-05-04

FCF payout ratio

17.86%

Last dividend

EUR 1.45

Payout ratio

12.58%

Shareholder yield

0.61%

Metric

Value

10Y price change

348.17%

10Y return CAGR

17.32%

10Y total return

393.67%

150-day SMA

EUR 235.71

15Y price change

780.3%

15Y return CAGR

16.94%

15Y total return

946.48%

1D price change

3.03%

1M price change

30.82%

1M total return

30.82%

1W price change

7.29%

1W total return

7.29%

1Y price change

22.36%

1Y return CAGR

22.92%

1Y total return

22.9%

20-day SMA

EUR 224.38

200-day SMA

EUR 241.87

20Y price change

466.08%

20Y return CAGR

10.68%

20Y total return

660.43%

3M price change

11.11%

3M total return

11.11%

3Y price change

301.39%

3Y return CAGR

59.9%

3Y total return

308.95%

50-day SMA

EUR 217.20

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 289.50

52-week high date

2026-02-19

52-week low

EUR 197.45

52-week low date

2026-10-14

5Y price change

170.82%

5Y return CAGR

22.98%

5Y total return

181.28%

6M price change

22.09%

6M total return

22.63%

All-time high

EUR 289.50

All-time high date

2026-02-19

All-time low

EUR 0.23

All-time low date

1981-02-02

Average true range (ATR)

EUR 9.15

Average volume

307.1K

Beta (1Y)

0.08

Beta (2Y)

0.69

Beta (5Y)

0.19

Change from 52-week high

-3.73%

Change from 52-week low

41.15%

Change from all-time high

-3.97%

Change from all-time low

122,366.96%

Change from open

2.92%

Day's gap

0.11%

Dollar volume

EUR 14.3M

High price

EUR 279.90

Low price

EUR 270.80

Monthly RSI

65.66

Open price

EUR 270.80

Position in 52-week range

86.81%

Previous close

EUR 270.50

Price vs 150-day SMA

17.94%

Price vs 20-day SMA

23.9%

Price vs 200-day SMA

14.94%

Price vs 50-day SMA

27.99%

Relative volume

0.17

RSI

79.59

Sharpe ratio

0.7

Sharpe ratio (3Y)

1.45

Sharpe ratio (5Y)

0.71

Sortino ratio

1.25

Sortino ratio (3Y)

2.44

Sortino ratio (5Y)

1.22

Volume

51.3K

Weekly RSI

65.31

YTD price change

16.51%

YTD total return

17.03%

Metric

Value

Float

120.1M

Shares change (QoQ)

-0.08%

Shares change (YoY)

-0.07%

Shares held by institutions

35.57%

Shares outstanding

190.7M

EBR/UCB (EBR/UCB)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/UCB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/UCB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/UCB

Frequently asked questions

EBR/UCB (EBR/UCB)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/UCB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/UCB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/UCB

Frequently asked questions